Joint Formulary & PAD

Diclofenac sodium - Pain & inflammation - musculoskeletal

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Suppositories
Associated Icons :
Restrictions / Comments :
 

Status 2

Green (see narrative)
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :
Important
Restricted to use when oral NSAIDs are not an option.
 

Status 3

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
Ibuprofen or naproxen are the preferred NSAIDS. Diclofenac for use if 1st-line options are ineffective / not tolerated. Restriced at Trusts to Rheumatology only.
 

Status 4

Non Formulary
Formulations :
  • Modified release capsules
  • Modified release tablets
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :
Important
Ibuprofen or naproxen are the preferred NSAIDS. Standard release diclofenac may be considered if 1st-line NSAIDs are ineffective / not tolerated.

Documentation

PAD Profile

ChemicalSubstance :
Diclofenac sodium
Indication :
Pain & inflammation - musculoskeletal
Group Name :
Keywords :
NSAIDs, rheumatism, PNMP, osteoarthritis
Brand Names Include :
Voltarol, Defenac, Dicloflex, Flamrase, Diclozip, Fenactol, Diclomax, Motifene
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
4

Other Indications

Below are listed other indications that Diclofenac sodium is used to treat.

Committee Recommendations (1)

A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. Consider initiation of  oral NSAID (ibuprofen or naproxen) as an adjunct to paracetamol if required.  Diclofenac or celecoxib (first line COX 2) may be considered as alternatives when ibuprofen and naproxen are ineffective / not tolerated. See the guidelines attached for further information